Document:

Exhibit

Execution Version

Exhibit 10.1

THIRD SUPPLEMENTAL INDENTURE
THIRD SUPPLEMENTAL INDENTURE (this “Third Supplemental Indenture”), dated as of August 9, 2018, between Peabody Energy Corporation, a Delaware corporation (the “Company”), and Wilmington Trust, National Association, as trustee under the Indenture referred to below (the “Trustee”). Capitalized terms used herein without definition shall have the meanings assigned to them in the Indenture. 
W I T N E S S E T H : 
WHEREAS, the Company has heretofore executed and delivered to the Trustee an indenture, dated as of February 15, 2017 (as amended, supplemented or otherwise modified to the date hereof, the “Indenture”), providing for the issuance of its 6.000% Senior Secured Notes due 2022 (the “2022 Notes”) and the issuance of its 6.375% Senior Secured Notes due 2025 (together with the 2022 Notes, the “Notes”); 
WHEREAS, Section 9.02 of the Indenture provides that the Company and the Trustee may, with the consent of the Holders of at least a majority in aggregate principal amount of the Notes then outstanding of each series (the “Requisite Consents”), enter into a supplemental indenture for the purpose of amending the Indenture; 
WHEREAS, the Company has solicited consents (the “Consent Solicitations”) from each Holder of the Notes upon the terms and subject to the conditions set forth in the Consent Solicitation Statement, dated as of July 30, 2018 (the “Consent Solicitation Statement”), as the same may be further amended, supplemented or modified; 
WHEREAS, the Consent Solicitations contemplate the proposed amendments to the Indenture (the “Proposed Amendments”) set forth herein and a supplemental indenture in respect of the Proposed Amendments being executed and delivered, with the operation of such Proposed Amendments being subject to, among other things, the receipt by the Company of the Requisite Consents at or prior to the Expiration Time (as defined in the Consent Solicitation Statement) and the payment by the Company of the aggregate Consent Fee (as defined in the Consent Solicitation Statement) payable in respect of the Consent Solicitations;
WHEREAS, the Company has received the Requisite Consents to effect the Proposed Amendments and has furnished to the Trustee evidence of such Requisite Consents; 
WHEREAS, pursuant to Section 9.02 of the Indenture, the Trustee is authorized to execute and deliver this Third Supplemental Indenture with the Requisite Consents;
WHEREAS, the Company has been authorized by a resolution adopted by its Board of Directors to enter into this Third Supplemental Indenture; 

WHEREAS, all other acts and proceedings required by law, the Indenture and the Fourth Amended and Restated Certificate of Incorporation and Amended and Restated By-Laws of the Company to execute and deliver this Third Supplemental Indenture, in accordance with its terms, have been duly done and performed; 
NOW, THEREFORE, in consideration of the premises and the covenants and agreements contained herein, and for other good and valuable consideration the receipt of which is hereby acknowledged, and for the equal and proportionate benefit of the Holders of the Notes, the Company and the Trustee hereby agree as follows: 
Section 1. Amendments to the Indenture.
 (a) Section 4.07(a) of the Indenture is hereby amended and restated in its entirety as follows, with additions shown as bolded, underlined text and deletions shown in strikethrough: 
		
	(a)
	The Company will not, and will not permit any of its Restricted Subsidiaries to, directly or indirectly:

		
	(1)
	declare or pay any dividend or make any distribution on its Equity Interests (other than dividends or distributions paid in the Company’s Qualified Equity Interests) held by Persons other than the Company or any of its Restricted Subsidiaries;

		
	(2)
	purchase, redeem or otherwise acquire or retire for value any Equity Interests of the Company held by Persons other than the Company or any of its Restricted Subsidiaries;

		
	(3)
	repay, redeem, repurchase, defease or otherwise acquire or retire for value, or make any payment on or with respect to, any Debt that is unsecured, Junior Lien Debt or Subordinated Debt (other than (x) a payment of interest or principal at Stated Maturity thereof or the redemption, repurchase or other acquisition or retirement for value of any Debt that is unsecured, Junior Lien Debt or Subordinated Debt in anticipation of satisfying a scheduled maturity, sinking fund or amortization or other installment obligation, in each case due within one year of the date of such redemption, repurchase, acquisition or retirement; or

		
	(4)
	make any Restricted Investment (all such payments and other actions set forth in clauses (1) through (4) above being collectively referred to as “Restricted Payments”); unless, at the time of, and after giving effect to, the proposed Restricted Payment:

		
	(i)
	no Default or Event of Default has occurred and is continuing as a consequence of such Restricted Payment;

		
	(ii)
	the Company could Incur at least $1.00 of additional Debt under the Fixed Charge Coverage Ratio Test set forth in Section 4.09(a) hereof;

		
	(iii)
	the aggregate amount expended for all Restricted Payments made on or after the Issue Date (excluding Restricted Payments permitted by clauses (2), (3), (4), (5), (6), or (12) or (13) of paragraph (b) of this Section 4.07), would not exceed the sum of:

		
	(A)
	50% of the aggregate amount of the Consolidated Net Income (or, if the Consolidated Net Income is a loss, minus 100% of the amount of the loss) accrued on a cumulative basis during the period, taken as one accounting period, beginning on the first fiscal quarter commencing after the Issue Date and ending on the last day of the Company’s most recently completed fiscal quarter for which internal financial statements are available at the time of such Restricted Payment; plus

		
	(B)
	100% of the aggregate net proceeds, including cash proceeds and the Fair Market Value of property other than cash, received by the Company (other than from a Subsidiary) after the Escrow Release Date,

		
	(i)
	from the issuance and sale of its Qualified Equity Interests, including by way of issuance of its Disqualified Equity Interests or Debt to the extent since converted into Qualified Equity Interests of the Company, or

		
	(ii)
	as a contribution to its common equity; plus

		
	(C)
	to the extent that any Unrestricted Subsidiary of the Company designated as such after the Escrow Release Date is redesignated as a Restricted Subsidiary after the Escrow Release Date, the Fair Market Value of the Company’s Restricted Investment in such Subsidiary as of the date of such redesignation; plus

		
	(D)
	to the extent that any Restricted Investment that was made after the Escrow Release Date is (a) sold for cash or otherwise cancelled, liquidated or repaid for cash, the cash return of capital with respect to such Restricted Investment (not included in Consolidated Net Income), less cost of disposition or (b) made in an entity that subsequently becomes a Restricted Subsidiary of the Company that is a Guarantor, the Fair Market Value of such Restricted Investment as of the date of such designation; plus

		
	(E)
	50% of any dividends received in cash by the Company or a Restricted Subsidiary of the Company that is a Guarantor after the Escrow Release Date from an Unrestricted Subsidiary of the Company, to the extent that such dividends were not otherwise included in the Consolidated Net Income of the Company for such period.

The amount of any Restricted Payment, if other than in cash, will be the Fair Market Value, on the date of the Restricted Payment, of the assets or securities proposed to be transferred or issued to or by the Company or such Restricted Subsidiary, as the case may be, pursuant to the Restricted Payment, except that the Fair Market Value of any non-cash dividend or distribution paid within 60 days after the date of its declaration shall be determined as of such date.

(b) Section 4.07(b) of the Indenture is hereby amended and restated in its entirety as follows, with additions shown as bolded, underlined text and deletions shown in strikethrough: 
(b) The provisions of Section 4.07(a) hereof will not prohibit:

(1) the payment of any dividend or distribution within 60 days after the date of declaration thereof if, at the date of declaration, such payment would comply with paragraph (a) of this Section 4.07;

(2) dividends or distributions by a Restricted Subsidiary payable, on a pro rata basis or on a basis more favorable to the Company, to all holders of any class of Equity Interests of such Restricted Subsidiary a majority of which is held, directly or indirectly through Restricted Subsidiaries, by the Company;
 
(3) the repayment, redemption, repurchase, defeasance or other acquisition or retirement for value of Debt that is unsecured, Junior Lien Debt or Subordinated Debt with the net cash proceeds of, or in exchange for, Permitted Refinancing Debt;

(4) the purchase, redemption or other acquisition or retirement for value of Equity Interests of the Company in exchange for, or out of the proceeds of a substantially concurrent offering (with any offering within 45 days deemed as substantially concurrent) of, Qualified Equity Interests of the Company or of a contribution to the common equity of the Company, including a contribution of the Capital Stock of the Company;
 

(5) the repayment, redemption, repurchase, defeasance or other acquisition or retirement of Debt that is unsecured, Junior Lien Debt or Subordinated Debt in exchange for, or out of the proceeds of, a cash or non-cash contribution to the capital of the Company or a substantially concurrent offering (with any offering within 45 days deemed as substantially concurrent) of, Qualified Equity Interests of the Company;

(6) any Investment acquired as a capital contribution to the Company, or made in exchange for, or out of the net cash proceeds of, a substantially concurrent offering (with any offering within 45 days deemed as substantially concurrent) of Qualified Equity Interests of the Company;

(7) the purchase, redemption or other acquisition or retirement for value of Equity Interests of the Company held by current officers, directors or employees or former officers, directors or employees (or their estates or beneficiaries under their estates or their immediate family members) of the Company or any of its Restricted Subsidiaries upon death, disability, retirement, severance or termination of employment or pursuant to any agreement under which the Equity Interests were issued, and Investments in the Equity Interests of the Company in connection with certain purchases or redemptions of Equity Interests held by officers, directors and employees or any employee pension benefit plan of a type specified in this Indenture; provided that the aggregate cash consideration paid therefor in any twelve-month period after the Issue Date does not exceed an aggregate amount of $5.0 million;

(8) the repayment, redemption, repurchase, defeasance or other acquisition or retirement for value of any Debt that is unsecured, Junior Lien Debt, Subordinated Debt or Disqualified Stock at a purchase price not greater than 101% of the principal amount or liquidation preference thereof in the event of (i) a change of control pursuant to a provision no more favorable to the holders thereof than in Section 4.14 hereof or (ii) an asset sale pursuant to a provision no more favorable to the holders thereof than in Section 4.10 hereof, provided that, in each case, prior to the repurchase the Company has made a Change of Control Offer to Purchase and repurchased all Notes issued under this Indenture that were validly tendered for payment in connection with the Change of Control Offer to Purchase;

(9) payments of dividends on the Company’s Common Stock or purchases by the Company of its Common Stock in an aggregate amount in any calendar year not to exceed $25.0 million, so long as, after giving pro forma effect to the payment of such Restricted Payment, the Total Leverage Ratio would not exceed 1.25 to 1.00; provided that no such Restricted Payment shall be made pursuant to this Section 4.07(b)(9) until the calendar year commencing on January 1, 2018;

(10) cash payments in lieu of fractional shares upon exercise of options or warrants or conversion or exchange of convertible securities, repurchases of Equity Interests deemed to occur upon the exercise of options, warrants or other convertible securities to the extent such securities represent a portion of the exercise price of such options, warrants or other convertible securities and repurchases of Equity Interests in connection with the withholding of a portion of the Equity Interests granted or awarded to a director or an employee to pay for the Taxes payable by such director or employee upon such grant or award;

(11) other Restricted Payments in an aggregate amount taken together with all other Restricted Payments made pursuant to this Section 4.07(b)(11) not to exceed $50.0 million since the Issue Date; and

(12) any payments made, or the performance of any of the transactions contemplated, in connection with the Refinancing Transactions; and

(13) other Restricted Payments in an aggregate amount not to exceed the sum of (i) $650.0 million since the Issue Date and (ii) 150.0 million per calendar year, commencing with calendar year 2019, with unused amounts in any calendar year carrying forward to and available for Restricted Payments in any subsequent calendar year; 

provided that, in the case of clauses (7), (8), (9) and, (11) and (13), no Default has occurred and is continuing or would occur as a result thereof.

(b) The final paragraph of Section 4.07 of the Indenture is hereby amended as follows, with additions shown as bolded, underlined text and deletions shown in strikethrough: 
For purposes of determining compliance with this Section 4.07, in the event that a Restricted Payment permitted pursuant to this Section 4.07 or a Permitted Investment meets the criteria of more than one of the categories of Restricted Payment described in clauses (1) through (12)(13) of Section 4.07(b) hereof or one or more clauses of the definition of Permitted Investments, the Company shall be permitted to classify such Restricted Payment or Permitted Investment on the date it is made, or later reclassify all or a portion of such Restricted Payment or Permitted Investment, in any manner that complies with this Section 4.07, and such Restricted Payment or Permitted Investment shall be treated as having been made pursuant to only one of such clauses of this Section 4.07 or of the definition of Permitted Investments. For purposes of covenant compliance, the amount of any Investment shall be the amount actually invested, without adjustment for subsequent increases or decreases in the value of such Investment, less any amount paid, repaid, returned, distributed or otherwise received in cash in respect of such Investment.

(c) Section 4.13(a) of the Indenture is hereby amended and restated in its entirety as follows, with additions shown as bolded, underlined text and deletions shown in strikethrough: 
(a) Subject to Article V hereof, the Issuer shall do or cause to be done all things necessary to preserve and keep in full force and effect its corporate existence, and the corporate, partnership or other existence of each of its Restricted Subsidiaries, in accordance with the respective organizational documents (as the same may be amended from time to time) of the Issuer or any such Restricted Subsidiary and the rights (charter and statutory), licenses and franchises of the Issuer and its Restricted Subsidiaries; provided, however, that the Issuer shall not be required to preserve any such right, license or franchise, or the corporate, partnership or other existence of any of its Restricted Subsidiaries, if the Board of Directors senior management of the Issuer shall determine that the preservation thereof is no longer desirable in the conduct of the business of the Issuer and its Restricted Subsidiaries, taken as a whole, and that the loss thereof is not adverse in any material respect to the Holders of the Notes.

Section 2. Effect and Operation of Third Supplemental Indenture.
This Third Supplemental Indenture shall be effective and binding immediately upon its execution and thereupon this Third Supplemental Indenture shall form a part of the Indenture for all purposes, and every Holder of a Note heretofore or hereafter authenticated and delivered under the Indenture shall be bound hereby; provided, however, that notwithstanding anything in the Indenture or this Third Supplemental Indenture to the contrary, the Proposed Amendments in this Third Supplemental Indenture shall not be operative until the Company has paid or caused to be paid the aggregate Consent Fee payable in respect of the Consent Solicitations. If the Consent Solicitations are terminated or withdrawn, or the aggregate Consent Fee is not paid for any reason, this Third Supplemental Indenture will not become operative. Following payment of the aggregate Consent Fee in respect of the Consent Solicitations, the Company will promptly deliver an Officer’s Certificate to the Trustee stating that the Proposed Amendments in this Third Supplemental Indenture have become operative. 
Section 3. Reference to and Effect on the Indenture.
(a) On and after the effective date of this Third Supplemental Indenture, each reference in the Indenture to “this Indenture,” “hereunder,” “hereof,” or “herein” shall mean and be a 

reference to the Indenture as supplemented by this Third Supplemental Indenture unless the context otherwise requires, and every Holder of a Note heretofore or hereafter authenticated and delivered shall be bound hereby. 
(b) Except as specifically amended above, the Indenture shall remain in full force and effect and is hereby ratified and confirmed.
Section 4. Construction.
Except as otherwise herein expressly provided or unless the context otherwise requires, the rules of construction set forth in Section 1.03 of the Indenture shall apply to this Third Supplemental Indenture mutatis mutandis. 
Section 5. Governing Law.
THIS THIRD SUPPLEMENTAL INDENTURE AND THE NOTES SHALL BE GOVERNED BY AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK. 
Section 6. Trustee Disclaimer.
The Trustee shall not be responsible in any manner whatsoever for or in respect of the validity or sufficiency of this Third Supplemental Indenture or for or in respect of the recitals contained herein, all of which are made solely by the Company. 
Section 7. Counterparts and Method of Execution.
The parties may sign multiple counterparts of this Third Supplemental Indenture. Each signed counterpart shall be deemed an original, but all of them together represent one and the same agreement. The exchange of copies of this Third Supplemental Indenture and of signature pages by facsimile or PDF transmission shall constitute effective execution and delivery of this instrument as to the parties hereto and may be used in lieu of the original instrument for all purposes.  Signatures of the parties hereto transmitted by facsimile or PDF shall be deemed to be their original signatures for all purposes
Section 8. Headings.
The headings of this Third Supplemental Indenture have been inserted for convenience of reference only, are not to be considered a part hereof, and shall in no way modify or restrict any of the terms or provisions hereof. 
Section 9. Separability.
Each provision of this Third Supplemental Indenture shall be considered separable and if for any reason any provision which is not essential to the effectuation of the basic purpose of this Third Supplemental Indenture or the Notes shall be invalid, illegal or unenforceable, the validity, 

legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby. 
Section 10. Successors.
All agreements of each of the Company in this Third Supplemental Indenture and the Notes shall bind their respective successors. All agreements of the Trustee, any additional trustee and any Paying Agents in this Third Supplemental Indenture shall bind their respective successors. 

[Signatures are on the following page.] 

IN WITNESS WHEREOF, the parties have caused this Third Supplemental Indenture to be duly executed all as of the date and year first written above. 
 
PEABODY ENERGY CORPORATION
	
				
	By:
	/s/ Walter L. Hawkins, Jr.

	 
	Name: Walter L. Hawkins, Jr.

	 
	Title: Senior Vice President, Finance

WILMINGTON TRUST, NATIONAL ASSOCIATION, as Trustee
	
				
	By:
	/s/ Shawn Goffinet

	 
	Name: Shawn Goffinet

	 
	Title: Assistant Vice President

[Signature Page to Peabody Energy Corporation – Third Supplemental Indenture]EX-10.1

 Exhibit 10.1 

EXECUTIVE EMPLOYMENT AGREEMENT 

This Executive Employment Agreement (the “Agreement”) is made by and between Destination Maternity Corporation (the
“Company”) and Marla A. Ryan (the “Executive”). 
 WHEREAS, Executive has been providing
services to the Company since May 29, 2018 (the “Start Date”) as the Company’s interim Chief Executive Officer; 

WHEREAS, the parties wish to enter into this Agreement to memorialize the terms of Executive’s employment by the Company. 

NOW, THEREFORE, in consideration of the foregoing and intending to be bound hereby, the parties agree as follows: 

1. Employment. The Executive’s employment pursuant to the terms and conditions of this Agreement shall commence as of the date of
this Agreement (the “Effective Date”). During the Term (as defined below), the Executive shall be employed as the Chief Executive Officer of the Company. In such position, the Executive shall render executive and management
services to the Company consistent with such position as may be reasonably assigned to the Executive by the Board of Directors of the Company (the “Board”). During the Term, the Executive shall report to and shall be subject
to the oversight and direction of the Board. 
 2. Term. Subject to earlier termination as provided for in
Section 6 hereof, the term of the Executive’s employment under this Agreement shall be for a period of three years from the Effective Date; provided, however, that, on the third anniversary of the Effective Date and on
each anniversary of such date (each, an “End Date”), the Executive’s employment hereunder shall renew automatically for a successive additional one (1) year period unless notice of
non-renewal is given by either party to the other at least ninety (90) days in advance of the next following End Date. The period of the Executive’s employment pursuant to the terms and conditions of
this Agreement is referred to herein as the “Term.” 
 3. Duties. Executive will devote her best efforts and
substantially all of her business time and services to the Company and its affiliates to perform such duties as may be customarily incident to her position and as may reasonably be assigned to her from time to time by the Board. Executive will not,
in any capacity, engage in other business activities or perform services for any other individual, firm or corporation without the prior written consent of the Board. During the Term, the Executive, with the prior written consent of the Board in
each instance, may serve on corporate, civic or charitable board of directors or committees and, without such consent, may manage personal investments, in each case so long as such activities are not in competition and do not interfere with the
performance of the Executive’s responsibilities hereunder. 
 4. Place of Performance. Executive will perform her services
hereunder at the principal executive offices of the Company in Moorestown, New Jersey; provided, however, that Executive may be required to travel from time to time for business purposes. 

5. Compensation and Indemnification. 

5.1. Base Salary. Executive’s annual salary will be $350,000 (the “Base Salary”), paid in accordance with
the Company’s payroll practices as in effect from time to time. The Base Salary will be reviewed annually by the Compensation Committee of the Board (the “Committee”). 

  
 1 

 5.2. Incentive Compensation. 

5.2.1. During the Term, Executive shall be eligible to receive an incentive bonus, calculated as a percentage (%) of the Company’s
adjusted EBITDA for each calendar year in the Term, as follows: (a) if estimated adjusted EBITDA level is less than or equal to the Company’s previous year’s actual adjusted EBITDA, 1.2% of the difference between estimated adjusted
EBITDA and $0; (b) if estimated adjusted EBITDA level is above last year’s actual adjusted EBITDA and below budgeted adjusted EBITDA, 1.2% of previous calendar year’s adjusted EBITDA plus 3.5% of the difference of estimated
adjusted EBITDA and last year’s actual adjusted EBITDA; and (c) if estimated adjusted EBITDA level is above budgeted adjusted EBITDA, 1.2% of previous calendar year’s adjusted EBITDA plus 3.5% of the difference of
budgeted adjusted EBITDA and the previous calendar year’s adjusted EBITDA plus 7.0% of the difference of estimated adjusted EBITDA and budgeted adjusted EBITDA (such bonus, the “Incentive Compensation”).
The Board shall determine, in good faith, in consultation with the Executive and the other members of the Company’s executive management team, the budgeted adjusted EBITDA (including the definition of EBITDA) on or before the start of the
calendar year for which such Incentive Compensation is payable and the estimated and actual adjusted EBITDA for each calendar year of the Term. For the 2018 calendar year, Executive shall be provided with Incentive Compensation under the formula
stipulated above, calculated based on adjusted EBITDA commencing with the second quarter through the end of the fourth quarter of the Company’s calendar year. The amount of such Incentive Compensation payable to Executive with respect to the
2018 calendar year shall be pro-rated from the Start Date, determined by multiplying adjusted EBITDA for the second through fourth quarters of the Company’s 2018 calendar year by the applicable
percentage, as determined in this Section 5.2.1, and multiplying the product thereof by a fraction, (i) the numerator of which shall be the number of days elapsed in the 2018 calendar year beginning on the Start Date
and (ii) the denominator of which shall be two hundred seventy six (276), and payable in one lump sum on or before two and one-half (2-1/2) months after the end of
the Company’s fiscal year. 
 5.2.2. Unless otherwise provided herein, the Incentive Compensation will be paid in twelve monthly
distributions after the Company’s estimated adjusted EBITDA is determined for the applicable calendar year, subject to adjustment up or down from time to time based on actual results compared to estimates and anticipated underpayments or
overpayments of monthly draws. Monthly payments of Incentive Compensation shall be subject to “true up” following the completion of the audited financial statements of the Company. In the event of any underpayment, the Company shall pay
such underpayment within thirty (30) days following the completion of such audited financial statements. In the event of any overpayment, the amount of such overpayment(s) shall be deducted from Executive’s Incentive Compensation for the
next succeeding monthly Incentive Compensation payment(s) until such overpayment has been absorbed by such deductions. In the event any overpayments have not been fully recovered upon the expiration or termination of the Term, the amount of such un-recovered overpayment(s) shall be deducted from any amounts payable by the Company pursuant to Section 6.1 of this Agreement, and if no amounts are payable by the Company pursuant to
Section 6.1 of this Agreement, the amount of such un-recovered overpayments shall be paid by Executive to the Company within thirty (30) days following the Company’s written
request. 
 5.2.3. Executive’s total cash compensation (i.e., Base Salary and the Incentive Compensation) shall not exceed $2,000,000
for any calendar year of the Term. 

  
 2 

 5.3. Equity Awards. 

5.3.1. Subject to approval by the Committee and the Board, for fiscal year 2018, Executive shall be entitled to receive a one-time equity grant with a grant date fair value of $600,000 (the “Initial Grant”) and a one-time equity grant for fiscal year 2018 with a grant date
fair value of $200,000 (the “2018 FY Grant,” and together with the Initial Grant, the “2018 LTIP”), calculated as of the grant date, which shall be no later than thirty (30) days from the
Effective Date. The 2018 LTIP shall be collectively allocated as follows: (i) 20% in restricted stock units, vesting in four equal annual increments beginning on the first anniversary of the Effective Date, as further set forth in the Restricted
Stock Unit Award Agreement (the “RSU Agreement”), attached hereto as Exhibit A, (ii) 50% in restricted stock units that vest based on the attainment of certain performance goals, as further provided in the
Performance RSU Agreement (the “Performance RSU Agreement”), attached hereto as Exhibit B; and (iii) 30% in stock options to purchase common stock in the Company, vesting in four equal annual increments
beginning on the first anniversary of the Effective Date, as further set forth in the Stock Option Award Agreement (the “Option Agreement”), attached hereto as Exhibit C. The 2018 LTIP will be subject to the
terms of the RSU Agreement, Performance RSU Agreement and Option Agreement and the Company’s 2005 Equity Incentive Plan, as amended and restated (the “Plan”). For future fiscal years in the Term, Executive will be
eligible for grants of equity under the Plan in an amount (which for the avoidance of doubt, may be less than the 2018 FY Grant) and on the terms as decided by the Committee in its sole discretion. 

5.3.2. In the event that the Committee determines that following the determination of the number of restricted stock units and stock options
to be granted to Executive pursuant to the 2018 LTIP a reasonable number of shares do not remain reserved under the Plan, the Committee will adjust the 2018 LTIP downwards in good faith. In the event of such downward adjustment in the 2018 LTIP, the
Company shall defer the remainder of the amount of the 2018 LTIP not granted hereunder, until the next calendar year in the Term when such shares become available for grant, as determined in the Committee’s good faith discretion. 

5.4. Participation in Employee Benefit Plans. During the Term, the Executive shall be entitled to participate in all employee benefit
plans, practices and programs maintained by the Company and made available to its senior executives generally including, without limitation, all pension, retirement, profit sharing, savings, medical, hospitalization, disability, life or travel
accident insurance, vacation, sick leave, perquisite and personal leave plans. The Executive’s participation in such plans, practices and programs shall be on the same basis and terms as are generally applicable to the other senior executives
of the Company. 
 5.5. Paid Time Off. Executive will be entitled to four (4) weeks of paid time off each year, in addition to
sick leave, personal days and holidays in accordance with Company policies in effect from time to time. The accrual, usage, carryover and expiration of such paid time off will be subject to the policies of the Company, as in effect from time to
time. 
 5.6. Business Expenses. During the Term, the Executive shall be entitled to reimbursement of necessary and reasonable
business expenses incurred by the Executive consistent with the Company’s policy. 

  
 3 

 5.7. Indemnification. During her employment and thereafter, the Company agrees to
indemnify and hold Executive harmless in connection with actual, potential or threatened actions or investigations related to Executive’s services for, or employment by, the Company and/or its subsidiaries in the same manner as other officers
and directors to the fullest extent provided in the Company’s by-laws and to be covered by D&O insurance to the maximum extent and length of coverage of any other officer or director of Company. 

5.8. Legal Fees. The Company will reimburse Executive for up to $18,750 for the reasonable legal fees incurred in connection with
the negotiation of this Agreement and related agreements and obligations. Such reimbursement will be made within sixty (60) days following execution of this Agreement and will be subject to Executive’s delivery of appropriate documentation
of these expenses. 
 6. Termination. Upon any cessation of her employment with the Company, Executive will be entitled only to such
compensation and benefits as described in this Section 6. Upon any cessation of her employment for any reason, unless otherwise requested by the Board, Executive agrees to resign immediately from all officer and director
positions she then holds with the Company and its affiliates. 
 6.1. Termination without Cause or for Good Reason. If
Executive’s employment by the Company ceases due to a termination by the Company without Cause (as defined below) or a resignation by Executive for Good Reason (as defined below) (each a “Qualifying Termination”),
Executive will be entitled to: 
 6.1.1. payment of all accrued and unpaid Base Salary through the date of such cessation; 

6.1.2. payment of any Incentive Compensation not yet paid, but earned for the calendar year in which the Executive’s employment is
terminated, in an amount determined by multiplying adjusted EBITDA for the period of the calendar year immediately preceding the date of termination by the applicable percentage, as determined pursuant to Section 5.2.1 and
multiplying the product thereof by a fraction, (i) the numerator of which shall be the number of days in the period from the beginning of such calendar year through the date of the termination of Executive’s employment and (ii) the
denominator of which shall be three hundred sixty-five (365) (provided, for purposes of clarity and the avoidance of doubt, that if a Qualifying Termination occurs in 2018, such pro-rata reduction not shall
occur, and amount of the Incentive Compensation in respect of 2018 (the “2018 Incentive Compensation”) payable under this Section 6.1.2 shall be determined pursuant to Section 5.2.1 calculated from the Start Date
through the date of the termination of Executive’s employment, and provided further that for a Qualifying Termination occurring in 2019 prior to the payment of the 2018 Incentive Compensation, the amount payable hereunder shall be (i) the
amount calculated from the Start Date through December 31, 2018 for the 2018 Incentive Compensation, and (ii) the amount calculated pursuant to the remainder of this Section 6.1.2 in respect of Incentive Compensation for 2019). Such
amount shall be reduced by any payments of Incentive Compensation already made to Executive for the calendar year in which Executive’s employment is terminated pursuant to Section 6.1. Such payment (if any) shall be
made on the Company’s next regularly scheduled payment date of the Incentive Compensation, as if Executive’s employment had not been terminated hereunder, provided that such payment shall be subject to any
true-up required under Section 5.2.2; 

  
 4 

 6.1.3. payment of (i) six (6) months of Executive’s Base Salary, in the event
that such Qualifying Termination occurs in the first twelve (12) months of the Term; (ii) nine (9) months of Executive’s Base Salary, in the event that such Qualifying Termination occurs in the second year of the Term; and
(iii) twelve (12) months of Executive’s Base Salary, in the event that such Qualifying Termination occurs in the third year of the Term or thereafter, in each case of (i), (ii) and (iii), payable in equal monthly installments; and 

6.1.4. waiver of the applicable premium otherwise payable for COBRA continuation coverage for Executive (and, to the extent covered
immediately prior to the date of such cessation, her spouse and eligible dependents) for a period equal to twelve (12) months. Except as otherwise provided in this Section 6.1, all compensation and benefits will cease
at the time of such cessation and the Company will have no further liability or obligation by reason of such cessation. 
 The payments and
benefits described in this Section 6.1 are in lieu of, and not in addition to, any other severance arrangement maintained by the Company. Notwithstanding any provision of this Agreement, the payments and benefits described
in Section 6.1 are conditioned on Executive’s execution and delivery to the Company, within 45 days following her cessation of employment, of a general release of claims against the Company and its affiliates in such
form as the Company may reasonably require (the “Release”). Subject to Section 6.4, below, and provided the Release is not revoked, the severance benefits described herein will begin to be paid or
provided (x) 15 days after the Release has been delivered (on the Company’s next regularly scheduled payroll date), if the 60-day period following the cessation of employment does not straddle two
calendar years; or (y) the later of 15 days after the Release has been delivered or the Company’s first regularly scheduled payroll date in the calendar year following the cessation of employment, if the
60-day period following such cessation straddles two calendar years. 
 6.2. Termination Following
a Change in Control. For cessations of employment due to a Qualifying Termination that occur during the two-year period following consummation of a Change in Control, (a) the references in
Section 6.1.3 to “6 months of Executive’s Base Salary”, “9 months of Executive’s Base Salary” and “12 months of Executive’s Base Salary” will be replaced with “24 months of
Executive’s Base Salary,” and the reference to “payable in equal monthly installments” will be replaced with “payable in one lump sum,” and (b) the reference in Section 6.1.4 to “12
months” will be replaced with “18 months”. For avoidance of doubt, the payment of these enhanced severance benefits is subject to the release requirements described at the end of Section 6.1. 

6.3. Other Terminations. If Executive’s employment with the Company ceases for any reason other than as described in
Section 6.1, above (including but not limited to termination (a) by the Company for Cause, (b) as a result of Executive’s death, (c) as a result of Executive’s Disability or (d) by Executive
without Good Reason), then the Company’s obligation to Executive will be limited solely to the payment of accrued and unpaid Base Salary through the date of such cessation, provided however, that in the case of the Executive’s death or
Disability, the 2018 LTIP will vest pro-rata through the date of Executive’s termination, and the Executive (or her estate as the case may be) shall be entitled to payment of a pro-rated portion of the 

  
 5 

 
Incentive Compensation and a pro-rated portion of the 2018 LTIP earned but not yet vested on the date of her death or disability. The 2018 LTIP and
Incentive Compensation payment pursuant to this Section 6.3, shall be based on actual performance of the Company through the termination date (and subject to any true-ups pursuant to
Section 5.2.2), and payable when such compensation would otherwise have become payable, notwithstanding Executive’s death or Disability. All compensation and benefits will cease at the time of such cessation and,
except as otherwise provided by COBRA, the Company will have no further liability or obligation by reason of such termination. The foregoing will not be construed to limit Executive’s right to payment or reimbursement for claims incurred prior
to the date of such termination under any insurance contract funding an employee benefit plan, policy or arrangement of the Company in accordance with the terms of such insurance contract. 

6.4. Compliance with Section 409A. 

6.4.1. If the termination giving rise to the payments described in Section 6.1 is not a “Separation from
Service” within the meaning of Treas. Reg. § 1.409A-1(h)(1) (or any successor provision), then the amounts otherwise payable pursuant to that section will instead be deferred without interest and will not be paid until Executive
experiences a Separation from Service. In addition, to the extent compliance with the requirements of Treas. Reg. § 1.409A-3(i)(2) (or any successor provision) is necessary to avoid the application of an additional tax under Section 409A
of the Code to payments due to Executive upon or following her Separation from Service, then notwithstanding any other provision of this Agreement (or any otherwise applicable plan, policy, agreement or arrangement), any such payments that are
otherwise due within six months following Executive’s Separation from Service (taking into account the preceding sentence of this paragraph) will be deferred without interest and paid to Executive in a lump sum immediately following that
six-month period. This paragraph should not be construed to prevent the application of Treas. Reg. § 1.409A-1(b)(9)(iii)(or any successor provision) to amounts payable hereunder. For purposes of the application of Treas. Reg. §
1.409A-1(b)(4)(or any successor provision), each payment in a series of payments will be deemed a separate payment. 
 6.4.2.
Notwithstanding anything in this Agreement to the contrary, to the extent an expense, reimbursement or in-kind benefit provided to Executive pursuant to this Agreement or otherwise constitutes a “deferral of compensation” within the
meaning of Section 409A of the Code (a) the amount of expenses eligible for reimbursement or in-kind benefits provided to the Executive during any calendar year will not affect the amount of expenses eligible for reimbursement or in-kind
benefits provided to the Executive in any other calendar year, (b) the reimbursements for expenses for which the Executive is entitled to be reimbursed shall be made on or before the last day of the calendar year following the calendar year in
which the applicable expense is incurred, and (c) the right to payment or reimbursement or in-kind benefits hereunder may not be liquidated or exchanged for any other benefit. 

6.5. Compliance with Section 280G. If any payment or benefit due to Executive from the Company or its subsidiaries or
affiliates, whether under this Agreement or otherwise, would (if paid or provided) constitute a Parachute Payment (as defined below), then notwithstanding any other provision of this Agreement or any other commitment of the Company, that payment or
benefit will be limited to the minimum extent necessary to ensure that no portion thereof will fail to be tax-deductible to the Company by reason of Section 280G of the Code; provided that such reduction shall only apply if the aggregate
after-tax value of the Parachute Payments 

  
 6 

 
retained by Executive (after giving effect to such reduction) is greater than the aggregate after-tax value (after giving effect to the excise tax imposed by Section 4999 of the Code) of the
Parachute Payments to Executive without any such reduction. The determination as to whether and to what extent payments and benefits under this Agreement or otherwise are required to be reduced in accordance with this paragraph will be made at the
expense of the Company by an independent expert selected by the Company. If multiple payments or benefits are subject to reduction under this paragraph, such payments or benefits will be reduced in the order that maximizes Executive’s economic
position (as determined by such independent expert). If there has been any underpayment or overpayment under this Agreement or otherwise as determined by the independent expert (whether at the time of initial determination or subsequently upon IRS
audit), the amount of such underpayment or overpayment shall forthwith be paid to Executive or refunded to the Company, as the case may be. 

6.6. Definitions. For purposes of this Agreement: 

6.6.1. “Cause” means: (a) conviction of or plea of guilty or nolo contendere to a crime that constitutes a felony
(or state law equivalent) or a crime that constitutes a misdemeanor involving moral turpitude; (b) alcohol abuse or use of controlled drugs (other than in accordance with a physician’s prescription); (c) willful misconduct or gross
negligence in the course of employment; (d) material breach of any published Company policy, including (without limitation) the Company’s ethics guidelines, insider trading policies or policies regarding employment practices;
(e) material breach of any agreement with a duty owed to the Company or any of its affiliates, after written notice and a period of ten (10) business days to cure; or (f) refusal to perform the lawful and reasonable directives of the
Board that are within the scope of the Executive’s employment. For avoidance of doubt, a separation from service that occurs as a result of a condition entitling the Executive to benefits under any Company sponsored or funded long term
disability arrangement will not constitute a termination “without Cause.” 
 6.6.2. “Change in
Control” means the first to occur of any of the events described in Section 1(f) of the Plan (or any successor provision). Notwithstanding the foregoing, a Change in Control will not be deemed to have occurred unless such event
would also be a Change in Control under Section 409A of the Code. 
 6.6.3. “Conflicting
Product” means any product, process or service which is the same as, similar to or competitive with any Company product (which includes third-party products that are distributed by Company), process, or service. Conflicting
Products include, but are not limited to, maternity and nursing apparel and related accessories. 
 6.6.4.
“Disability” shall have the meaning set forth in the Plan. 
 6.6.5. “Good
Reason” means any of the following, without the Executive’s prior consent: (a) a change in title or removal from the Board; (b) a reduction in Base Salary or a reduction in the percentage thresholds used to calculate the
Incentive Compensation, in a manner designed to reduce the overall Incentive Compensation payable to Executive; or (c) a relocation of the Executive’s principal worksite more than 50 miles. However, none of the foregoing events or
conditions will constitute Good Reason unless the Executive provides the Company with written objection to the event or condition within 30 days following the occurrence thereof, the Company does not cure the event or condition within 30 days of
receiving that written objection, and the Executive resigns her employment within 30 days following the expiration of that cure period. 

  
 7 

 6.6.6. “Parachute Payment” has the same
meaning as used in Section 280G(b)(2) of the Code. 
 6.6.7. “Restricted Period” means the period immediately
following Executive’s cessation of employment equal to (a) nine (9) months, in the case of cessation of employment (without regard to whether such cessation was initiated by the Company or by Executive) in the first twelve (12) months
of the Term, and (b) twelve (12) months, in the case of cessation of employment (without regard to whether such cessation was initiated by the Company or by Executive) at any time after the first twelve (12) months of the Term.” 

7. Confidential Information. “Confidential Information” means information which the Company regards as
confidential or proprietary and which Executive learns or develops during or related to her employment, including, but not limited to, information: 
  

	 	a.	 relating to the Company’s products, suppliers, pricing, costs, sourcing, design, fabric and distribution
processes; 

  

	 	b.	 relating to the Company’s marketing plans and projections; 

 

	 	c.	 consisting of lists of names and addresses of the Company’s employees, agents, factories and suppliers;

  

	 	d.	 relating to the methods of importing and exporting used by the Company; 

 

	 	e.	 relating to manuals and procedures created and/or used by the Company; 

 

	 	f.	 consisting of trade secrets or other information that is used in the Company’s business, and which give
the Company an opportunity to obtain an advantage over competitors who do not know such trade secrets or how to use the same; 

  

	 	g.	 consisting of software in various stages of development (source code, object code, documentation, flow charts),
specifications, models, data and customer information; 

  

	 	h.	 consisting of financial information and financial analysis prepared by the Company or used by the Company;

  

	 	i.	 consisting of legal information; and 

 

	 	j.	 relating to contracts. 

Executive assigns to Company any rights she may have in any Confidential Information. Executive shall not disclose any Confidential Information
to any third-party or use any Confidential Information for any purposes other than as authorized by the Company. Executive agrees not to disclose to Company or use for her benefit any confidential information that she may possess from any prior
employers or other sources. 

  
 8 

 8. Surrender of Materials. Executive hereby agrees to deliver to the Company promptly
upon request or on the date of termination of Executive’s employment, all documents, copies thereof and other materials in Executive’s possession or control pertaining to the business of the Company and its customers, including, but not
limited to, Confidential Information and Inventions (and each and every copy, abstract, summary or reproduction of the same made by or for Executive or acquired by Executive) and any other written or digital documents, information, access to files
or information, or property (including but not limited to credit cards, laptop computers, cellphones, and security or identification cards) requested by the Board. Executive further agrees that any property situated on the premises of, and owned by,
the Company or its subsidiaries or affiliates, including disks and other storage media, filing cabinets or other work areas, is subject to inspection by Company’s personnel at any time with or without notice. 

9. Non-Competition and Non-Solicitation. Executive
acknowledges that the Company has developed and maintains at great expense, a valuable supplier network, supplier contacts, many of which are of longstanding, product designs, and other information of the type described in
Section 7 of this Agreement, and that in the course of her employment (or continued employment) by the Company, Executive will be given Confidential Information concerning such suppliers and products, including information
concerning such suppliers’ purchasing personnel, policies, requirements, and preferences, and such product’s design, manufacture and marketing. 

9.1. Non-Competition. Accordingly, Executive agrees that during the period of Executive’s
employment with the Company and its affiliates and for the Restricted Period, Executive will not directly or indirectly: 
 9.1.1. Provide
services for a business or enterprise that, in its previous fiscal year, generated 20% or more of its gross revenue from the design, manufacture and/or sale of Conflicting Products. This subparagraph applies in the following geographic areas:
(a) states and commonwealths of the United States; (b) the District of Columbia; and (c) any foreign country. Furthermore, this subparagraph only applies in the foregoing geographic areas to the extent that the Company has designed,
sold or manufactured Conflicting Products within the relevant territory (or has undertaken preparations to do so) within the year prior to the termination of Executive’s employment; or 

9.1.2. Provide services for the following entities (including any of their respective divisions, subsidiaries, or affiliates): (a) Gap Inc.,
(b) J.C. Penney Corporation, Inc., (c) Target Corporation, (d) Macy’s, Inc., (e) Sears Holding Corporation, (f) Bed Bath and Beyond, Inc., (g) Amazon.com, Inc., (h) Boscov’s (i) Century 21 Department Store, or
(j) Kohl’s Corporation. Such list of entities may be modified from time to time in the sole reasonable discretion of the Board. Executive is not permitted to provide services to such businesses regardless of the amount of Conflicting
Product sales generated by such businesses. 
 9.2. Non-Solicitation. During the period of
Executive’s service with the Company and its affiliates and for twelve (12) months thereafter, Executive will not induce, attempt to induce (or in any way assist any other person in inducing or attempting to induce) any employee,
consultant, supplier, licensor, licensee, contractor, agent, strategic partner, distributor or other person to terminate or modify any agreement, arrangement, relationship or course of dealing with the Company. Further, during such period Executive
will not directly or indirectly, on Executive’s own behalf or on behalf of any other person or entity, employ or solicit for employment: (a) any current Company employee or agent; or (b) any former Company employee or agent who
provided services to the Company within the prior 12-month period. 

  
 9 

 9.3. Non-disparagement. During the Term and
thereafter, Executive shall not make or publish any disparaging statements (whether written or oral) regarding the Company or its affiliates, officers or employees (the “Company Parties”) or defame any of the Company Parties,
including but not limited to the services, business ventures, integrity, veracity, or personal or professional reputation of any of the Company Parties, in any matter whatsoever. 

9.4. Remedies and Injunctive Relief. Executive acknowledges that any breach by her of the provisions of this
Section 9 (the “Restrictive Covenants”), whether or not willful, will cause continuing and irreparable injury to the Company for which monetary damages alone would not be an adequate remedy.
Executive shall not, in any action or proceeding to enforce the Restrictive Covenants, assert the claim or defense that such an adequate remedy at law exists. If there is a breach or threatened breach of any of the Restrictive Covenants, or any
other obligation contained in this Agreement, the Company shall be entitled to an injunction restraining Executive from any such breach without the necessity of proving actual damages, and Executive waives the requirement of posting a bond. Nothing
herein, however, shall be construed as prohibiting the Company from pursuing other remedies for such breach or threatened breach. In the event of any action or proceeding concerning the Restrictive Covenants, Executive will reimburse the Company for
its reasonable costs and attorney’s fees incurred in connection with such action or proceeding if the Company is determined by the court or other factfinder to have substantially prevailed in such matter. 

9.5. Notification of Subsequent Employer. Executive agrees to disclose the existence and terms of the Restrictive Covenants to any
person for whom Executive performs or proposes to perform services for during the Restricted Period. 
 9.6. Executive
Acknowledgement. Executive acknowledges that the Restrictive Covenants are reasonable and necessary to protect the legitimate interests of the Company and its affiliates, that the duration and scope of the Restrictive Covenants are reasonable
given Executive’s position within the Company, and that the Company would not have hired Executive, entered into this Agreement or otherwise agreed to provide the payments, rights and benefits described herein in the absence of Executive’s
execution of this Agreement 
 9.7. Tolling of Periods and Enforceability. The periods in Section 9.1 and
Section 9.2 shall be tolled during (and shall be deemed automatically extended by) any period in which Executive is in violation of the provisions of this Section 9. If a final and non-appealable judicial determination is made that any of the provisions of this Section 9 constitutes an unreasonable or otherwise unenforceable restriction against Executive, the
provisions of this Section 9 will not be rendered void but will be deemed to be modified to the minimum extent necessary to remain in force and effect for the longest period and largest geographic area that would not
constitute such an unreasonable or unenforceable restriction. 
 10. Intellectual Property Rights. 

10.1. The Executive acknowledges and agrees that all writings, works of authorship, technology, inventions, discoveries, ideas and other work
product of any nature whatsoever, that are created, prepared, produced, authored, conceived or reduced to practice by the Executive individually or jointly with others during the Term and relating in any way to the business or contemplated business
of the Company (regardless of when or where the Inventions are prepared or whose equipment or other resources is used in 

  
 10 

 
preparing the same) and all printed, physical and electronic copies, all improvements, rights and claims related to the foregoing, and other tangible embodiments thereof (collectively,
“Inventions”), as well as any and all rights in and to copyrights, trade secrets, trademarks (and related goodwill), patents and other intellectual property rights therein arising in any jurisdiction throughout the world and
all related rights of priority under international conventions with respect thereto, including all pending and future applications and registrations therefor, and continuations, divisions, continuations-in-part, reissues, extensions and renewals thereof (collectively, “Intellectual Property Rights”), shall be the sole and exclusive property of the Company. The Executive
acknowledges that, by reason of being employed by the Company at the relevant times, to the extent permitted by law, all of the Inventions consisting of copyrightable subject matter is “work made for hire” as defined in 17 U.S.C. §
101 and such copyrights are therefore owned by the Company. To the extent that the foregoing does not apply, the Executive hereby irrevocably assigns to the Company, for no additional consideration, the Executive’s entire right, title and
interest in and to all Inventions and Intellectual Property Rights therein, including the right to sue, counterclaim and recover for all past, present and future infringement, misappropriation or dilution thereof, and all rights corresponding
thereto throughout the world. Nothing contained in this Agreement shall be construed to reduce or limit the Company’s rights, title or interest in any Inventions or Intellectual Property Rights so as to be less in any respect than that the
Company would have had in the absence of this Agreement. 
 10.2. Executive agrees that, from time to time, as may be requested by the
Company and at the Company’s sole cost and expense, Executive shall do any and all things that the Company may reasonably deem useful or desirable to establish or document the Company’s exclusive ownership throughout the United States of
America or any other country of any and all Intellectual Property Rights in any such Inventions, including the execution of appropriate copyright and/or patent applications or assignments. To the extent Executive has any Intellectual Property Rights
in the Inventions that cannot be assigned in the manner described above, Executive unconditionally and irrevocably waives the enforcement of such Intellectual Property Rights. This Section 10.2 is subject to and shall not
be deemed to limit, restrict or constitute any waiver by the Company of any Intellectual Property Rights of ownership to which the Company may be entitled by operation of law by virtue of the Company’s being Executive’s employer. Executive
further agrees that, from time to time, as may be requested by the Company and at the Company’s sole cost and expense, Executive shall assist the Company in every proper and lawful way to obtain and from time to time enforce Intellectual
Property Rights relating to Inventions in any and all countries. To this end, Executive shall execute, verify and deliver such documents and perform such other acts (including appearances as a witness) as the Company may reasonably request for use
in applying for, obtaining, perfecting, evidencing, sustaining, and enforcing such Intellectual Property Rights and the assignment thereof. In addition, Executive shall execute, verify, and deliver assignments of such Intellectual Property Rights to
the Company or its designees. Executive’s obligation to assist the Company with respect to Intellectual Property Rights relating to such Inventions in any and all countries shall continue beyond the termination of Executive’s employment
with the Company. 

  
 11 

 11. Other Conditions of Employment. Executive shall be subject to other terms
and conditions of employment as set forth in: (a) the prevailing Company Team Member Handbook, (b) the prevailing Company insider trading policies, (c) any prevailing clawback or anti-hedging policies, and (d) any other Company
policies, all of which shall be subject to interpretation and change from time to time at the sole discretion of the Company, so long as such terms and conditions are not materially inconsistent with the terms hereof. 

12. Miscellaneous. 
 12.1.
No Liability of Officers and Directors Upon Insolvency. Notwithstanding any other provision of the Agreement, Executive hereby (a) waives any right to claim payment of amounts owed to her, now or in the future, pursuant to this Agreement
from directors or officers of the Company if the Company becomes insolvent, and (b) fully and forever releases and discharges the Company’s officers and directors from any and all claims, demands, liens, actions, suits, causes of action or
judgments arising out of any present or future claim for such amounts. 
 12.2. Other Agreements. Executive represents and
warrants to the Company that there are no restrictions, agreements or understandings whatsoever to which she is a party that would prevent or make unlawful her execution of this Agreement, that would be inconsistent or in conflict with this
Agreement or Executive’s obligations hereunder, or that would otherwise prevent, limit or impair the performance by Executive of her duties under this Agreement. 

12.3. Cooperation. Executive agrees that, upon reasonable notice and without the necessity of the Company obtaining a subpoena or court
order, Executive shall provide reasonable cooperation in connection with any suit, action or proceeding (or any appeal from any suit, action or proceeding), and any investigation and/or defense of any claims asserted against the Company, its
subsidiaries and affiliates, its predecessors and successors, and all of the respective current or former directors, officers, employees, shareholders, partners, members, agents or representatives of any of the foregoing, which relates to events
occurring during Executive’s employment with the Company, its subsidiaries and affiliates as to which Executive may have relevant information (including but not limited to furnishing relevant information and materials to the Company, or its
designee and/or providing testimony at depositions and at trial), provided that with respect to such cooperation occurring following termination of employment, the Company shall reimburse Executive for expenses reasonably incurred in connection
therewith, and further provided that any such cooperation occurring after the termination of Executive’s employment shall be scheduled to the extent reasonably practicable so as not to unreasonably interfere with Executive’s business or
personal affairs. 
 12.4. Successors and Assigns. The Company may assign this Agreement to any successor to its assets and
business by means of liquidation, dissolution, sale of assets or otherwise. For avoidance of doubt, a termination of Executive’s employment by the Company in connection with a permitted assignment of the Company’s rights and obligations
under this Agreement is not a termination “without Cause” so long as the assignee offers employment to Executive on the terms herein specified (without regard to whether Executive accepts employment with the assignee). The duties of
Executive hereunder are personal to Executive and may not be assigned by her. 

  
 12 

 12.5. Governing Law and Enforcement. This Agreement will be governed by and
construed in accordance with the laws of the State of Delaware, without regard to the principles of conflicts of laws. Any legal proceeding arising out of or relating to this Agreement will be instituted in a state or federal court in the State of
Delaware, and Executive and the Company hereby consent to the personal and exclusive jurisdiction of such court(s) and hereby waive any objection(s) that they may have to personal jurisdiction, the laying of venue of any such proceeding and any
claim or defense of inconvenient forum. 
 12.6. Dispute Resolution and Arbitration. Except as otherwise provided herein (including
Section 9.4), any and all justiciable controversies, claims or disputes that Executive may have against the Company and/or the Company may have against Executive arising out of, relating to, or resulting from Executive’s employment with
the Company, or the separation of Executive’s employment with the Company, including claims arising out of or related to this Agreement, shall be subject to mandatory arbitration (“Mandatory Arbitration”) as set forth
herein. The mutual obligations by the Company and Executive to arbitrate differences provide mutual consideration for this Mandatory Arbitration provision. Prior to commencing arbitration, if any such matter cannot be settled through negotiation,
then the parties agree first to try in good faith to settle the dispute by mediation through a mediator selected by the mutual agreement of both parties. If any such matters cannot be resolved by mediation within 30 days of the Company or Executive
requesting mediation (or such longer period as to which Executive and the Company agree in writing), they shall be finally resolved by final and binding arbitration. The parties shall select a neutral arbitrator and/or arbitration sponsoring
organization by mutual agreement. If the parties are not able to mutually agree to an arbitrator and/or arbitration sponsoring organization, the arbitration will be held under the auspices of the American Arbitration Association
(“AAA”), and except as otherwise provided in this Agreement, shall be in accordance with the then current Employment Arbitration Rules of the AAA, which may be found at www.adr.org or by using an internet search engine to
locate “AAA Employment Arbitration Rules”). The arbitrator, and not any federal, state or local court or agency, shall have the exclusive authority to resolve any dispute relating to the interpretation, applicability,
enforceability or formation of this Mandatory Arbitration provision. Subject to remedies to which a party to the arbitration may be entitled under applicable law, each party shall pay the fees of its own attorneys, the expenses of its witnesses and
all other expenses connected with presenting its case. Other costs of the arbitration, including the cost of any record or transcripts of the arbitration, administrative fees, the fee of the arbitrator, and all other fees and costs, shall be borne
by the Company. All Arbitral awards shall be final and binding, and the arbitration will be conducted in the City of New York, New York, in accordance with the Federal Arbitration Act (9 U.S.C. §§ 1 et seq.). A judgement of a court of
competent jurisdiction shall be entered upon the award made pursuant to the arbitration. 
 12.7. Waivers. The waiver by either party
of any right hereunder or of any breach by the other party will not be deemed a waiver of any other right hereunder or of any other breach by the other party. No waiver will be deemed to have occurred unless set forth in a writing. No waiver will
constitute a continuing waiver unless specifically stated, and any waiver will operate only as to the specific term or condition waived. 

12.8. Severability. The various parts of this Agreement are intended to be severable. Should any part be rendered or declared invalid be
reason of any legislation or by a decree of a court of competent jurisdiction, such part shall be deemed modified to the extent required by such legislation or decree and the invalidation or modification of such part shall not invalidate or modify
the remaining parts hereof. Without limiting the generality of the foregoing, if the scope of any covenant contained in this Agreement is too broad to permit enforcement to its full extent, such covenant shall be enforced to the maximum extent
permitted by law. Executive agrees that such scope may be judicially modified accordingly. 

  
 13 

 12.9. Survival. This Agreement will survive the cessation of Executive’s
employment to the extent necessary to fulfill the purposes and intent of the Agreement. 
 12.10. Notices. All notices, requests, and
other communications hereunder shall be in writing and shall be deemed to have been duly given if delivered by hand, emailed (with confirmation copy by mail) or mailed, certified or registered mail, return receipt requested, with postage prepaid, to
the following addresses or to such other address as either party may designate by like notice, and shall be deemed given when so delivered by hand or emailed, or if mailed, three days after mailing (one business day in the case of express mail or
overnight courier service). 
 If to the Company, to:        Destination Maternity Corporation 

                        
                    232 Strawbridge Drive 

                        
                    Moorestown, New Jersey 08057 

                        
                    Attention: General Counsel 

If to the Executive, to the Executive’s most recent address as shown on the books and records of the Company and its affiliates and to
such other or additional person or persons as either party shall have designated to the other party in writing by like notice. 
 12.11.
Entire Agreement; Amendments. This Agreement contains the entire agreement and understanding of the parties hereto relating to the subjects addressed in those documents, and merges and supersedes all prior and contemporaneous discussions,
agreements and understandings of every nature relating to that subject matter. This Agreement may not be changed or modified, except by an agreement in writing signed by each of the parties hereto. 

12.12. Withholding. All payments (or transfers of property) to Executive will be subject to tax withholding to the extent required by
applicable law. 
 12.13. Defend Trade Secrets Act Compliance. Executive will not be held criminally or civilly liable under any
federal or state trade secret law for Executive’s disclosure of a trade secret that is made in confidence to federal, state or local government official or to an attorney, provided that such disclosure is: (a) solely for the purpose of
reporting or investigating a suspected violation of law; or (b) made in a complaint or other document filed in a lawsuit or other proceeding, if such filing is made under seal. If Executive files a lawsuit for retaliation by the Company for
reporting a suspected violation of law, Executive may disclose the trade secret to the Executive’s attorney and use the trade secret information in related court proceedings, provided that Executive files any document containing the trade
secret information under seal and does not disclose the trade secret, except pursuant to court order. 
 12.14. Section Headings. The
headings of sections and paragraphs of this Agreement are inserted for convenience only and will not in any way affect the meaning or construction of any provision of this Agreement. 

12.15. Counterparts; Facsimile. This Agreement may be executed in multiple counterparts (including by facsimile signature), each
of which will be deemed to be an original, but all of which together will constitute but one and the same instrument. 

  
 14 

 IN WITNESS WHEREOF, the Company has caused this Agreement to be executed by its duly
authorized officer, and Executive has executed this Agreement, in each case on November 1, 2018. 
  

					
	COMPANY
	
	DESTINATION MATERNITY CORPORATION
		
	By:	 	 /s/ Rodney Schriver

		 	Name:	 	Rodney Schriver
		 	Title:	 	 Senior Vice President and
 Chief Accounting
Officer

	
	EXECUTIVE
	
	/s/ Marla A. Ryan
	Marla A. Ryan

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00288-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00288-of-00352.parquet"}]]